# Passage Bio funding: rounds and investors > Passage Bio has raised $380M across 3 rounds since 2019. Investors include Versant Ventures, OrbiMed and Vivo Capital. Every round with its source. Source: https://millionrounds.com/company/passage-bio (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *Passage Bio* 3 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Funding summary Updated 26 Oct 2026 **$380M** raised across 3 rounds since 2019, from 3 sources **$116M** Series A **$110M** Series B **$154M** Round - **Latest round:** Round, $154M Jan 2021 - **Step-up i:** 1.4× - **Investors:** 12 (1 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2019 2020 2021 **$116M** Series A **$110M** Series B **$154M** Round - **First round:** Series A, $116M - **Biggest round:** $154M - **Usual gap between rounds:** 16 months ## The rounds - **Jan 2021** Round **$154M** *1 new* *3 returning* [OrbiMed](https://millionrounds.com/fund/orbimed) [Versant Ventures](https://millionrounds.com/fund/versant-ventures) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) [Lilly Asia Ventures](https://millionrounds.com/fund/lilly-asia-ventures) Source recorded - **Sept 2019** Series B **$110M** *6 new* *1 returning* [Access Industries](https://millionrounds.com/fund/access-industries) Lead [OrbiMed](https://millionrounds.com/fund/orbimed) [Versant Ventures](https://millionrounds.com/fund/versant-ventures) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) [Frazier Healthcare Partners](https://millionrounds.com/fund/frazier-healthcare-partners) Lily Asia Ventures Reported by Endpts - **Feb 2019** Series A **$116M** *5 new* [Versant Ventures](https://millionrounds.com/fund/versant-ventures) [Lily Asia](https://millionrounds.com/fund/lily-asia) New Leaf OrbiMed Advisors/ Frazier Healthcare Vivo Reported by Biocentury ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2019 **Series B** 2019 **Round** 2021 [Versant Ventures](https://millionrounds.com/fund/versant-ventures) [OrbiMed](https://millionrounds.com/fund/orbimed) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) [Access Industries](https://millionrounds.com/fund/access-industries) L [Lilly Asia Ventures](https://millionrounds.com/fund/lilly-asia-ventures) [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) [Frazier Healthcare Partners](https://millionrounds.com/fund/frazier-healthcare-partners) [Lily Asia](https://millionrounds.com/fund/lily-asia) Lily Asia Ventures New Leaf ## Everyone who backed them [Versant Ventures](https://millionrounds.com/fund/versant-ventures) VC firm **3** rounds [OrbiMed](https://millionrounds.com/fund/orbimed) Private equity **2** rounds [Vivo Capital](https://millionrounds.com/fund/vivo-capital) Private equity **2** rounds [Access Industries](https://millionrounds.com/fund/access-industries) Corporate VC **1** round, led 1 [Lilly Asia Ventures](https://millionrounds.com/fund/lilly-asia-ventures) VC firm **1** round [New Leaf Venture Partners](https://millionrounds.com/fund/new-leaf-venture-partners) VC firm **1** round [Frazier Healthcare Partners](https://millionrounds.com/fund/frazier-healthcare-partners) Private equity **1** round [Lily Asia](https://millionrounds.com/fund/lily-asia) Investment firm **1** round Lily Asia Ventures no record of our own yet **1** round New Leaf no record of our own yet **1** round OrbiMed Advisors/ Frazier Healthcare no record of our own yet **1** round Vivo no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=passage-bio). ## Also claim to have backed them This firm lists Passage Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [Frazier Life Sciences](https://millionrounds.com/fund/frazier-life-sciences) VC firm Per its own site ## Quick answers about Passage Bio ### Who invested in Passage Bio? Passage Bio's investors include Versant Ventures, OrbiMed, Vivo Capital, Access Industries and Lilly Asia Ventures, and 7 more on record. ### How much has Passage Bio raised? Passage Bio has raised $380M across 3 rounds since 2019. ### When did Passage Bio last raise? Passage Bio's most recent round was an Undisclosed round of $154M in Jan 2021. ### What was Passage Bio's biggest round? Its most recent round, $154M in Jan 2021, is also its largest on record. ### Who backed Passage Bio first? Passage Bio's first round on record, in Feb 2019, was backed by Versant Ventures, Lily Asia and New Leaf and 2 others. ### What stage is Passage Bio at? Passage Bio's latest named round is an Undisclosed round, in Jan 2021. ### Where is Passage Bio based? Passage Bio is based in the United States. ### Who led Passage Bio's rounds? Access Industries led the Series B in 2019. ## Companies like Passage Bio In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app